Journal of Proteome Research · 2008 · 54 citations · 36 references
MedicineMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyChannel StructureEnzyme InhibitionIon Channel PharmacologyLigand BindingPeptide ChemistryPeptide Drug DiscoveryChannel IsoformsDrug Binding To Ion ChannelsIon Channel Structure-function RelationshipsPeptide Drug DevelopmentPeptide SelectivityPeptide Structure - Activity RelationshipsPeptide Structure-activity RelationshipsSelectivity
The low selectivity of Kv1 peptide inhibitors for specific isoforms makes them poor candidates for the development of theraputics. Using combined approaches, we showed that the Kv1 turret is the critical determinant for ADWX-1 peptide inhibitor selectivity of Kv1.3 over Kv1.1. Mutation of Kv1.1 turret residues to match the sequence of Kv1.3 lead to increased inhibition of Kv1.1 activity. These studies may lead to improvements in peptide inhibitor drug development.
36
The Amber biomolecular simulation programs
David A. Case, Thomas E. Cheatham, Tom Darden et al. · Journal of Computational Chemistry · 2005 · 9.6K citations · Full text
SWISS-MODEL: an automated protein homology-modeling server
Torsten Schwede · Nucleic Acids Research · 2003 · 5.7K citations · Full text
Structure validation by Cα geometry: ϕ,ψ and Cβ deviation
Simon C. Lovell, Ian Davis, W.B. Arendall et al. · Proteins Structure Function and Bioinformatics · 2003 · 4.6K citations